Bio-Techne
TECH
#1637
Rank
NZ$18.18 B
Marketcap
$115.06
Share price
-1.12%
Change (1 day)
-1.33%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2023 (TTM): $2.55

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is $2.74. In 2022 the company made an earnings per share (EPS) of $2.92 an increase over its 2021 EPS that were of $2.35.

EPS history for Bio-Techne from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.55-12.73%
2022$2.9224.35%
2021$2.3517.98%
2020$1.99-10.94%
2019$2.23101.57%
2018$1.11-17.53%
2017$1.3439.37%
2016$0.96-17.23%
2015$1.16-14.97%
2014$1.371.29%
2013$1.353.68%
2012$1.30-1.97%
2011$1.331.67%
2010$1.317.14%
2009$1.22-1.06%
2008$1.2319.41%
2007$1.0319.1%
2006$0.8710.56%
2005$0.7929.5%
2004$0.6113.05%
2003$0.5468.43%
2002$0.32-17.05%
2001$0.3817.33%
2000$0.3348.51%
1999$0.2223.17%
1998$0.1813.89%
1997$0.1642.57%
1996$0.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$26.77 877.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$9.98-464.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.68 253.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.99 410.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.54-7.38%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$14.92 444.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.64-159.87%๐Ÿ‡บ๐Ÿ‡ธ USA